Skip to content

Horizon Pump Y-Type Blood Set

by Mcgaw, Inc.

510(k) K922637

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

3 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK922637 Date4 Jun 1993ClearedStatusActive

Recalls

11 recalls · 3 ongoing · FDA

  • 3 recalls, same reason

    • Ongoing Z-0620-2026 FDA Class II initiated 29 Oct 2025
    • Ongoing Z-0619-2026 FDA Class II initiated 29 Oct 2025
    • Ongoing Z-0618-2026 FDA Class II initiated 29 Oct 2025

    Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

  • 4 recalls, same reason

    • Terminated Z-2548-2021 FDA Class II initiated 10 Aug 2021
    • Terminated Z-2553-2021 FDA Class II initiated 10 Aug 2021
    • Terminated Z-2559-2021 FDA Class II initiated 10 Aug 2021
    • Terminated Z-2560-2021 FDA Class II initiated 10 Aug 2021

    Leakage of the pump set within the cassette portion of the pump sets, potential for delays in administration of medications, under-delivery or incomplete dosing and bloodstream infections.

  • 3 recalls, same reason

    • Terminated Z-0935-2020 FDA Class II initiated 20 Nov 2019
    • Terminated Z-0937-2020 FDA Class II initiated 20 Nov 2019
    • Terminated Z-0939-2020 FDA Class II initiated 20 Nov 2019

    Potential for leakage at the joint between the blood filters and tubing

    • Terminated Z-0718-2010 FDA Unclassified (pre-2012) initiated 24 Nov 2009

    System error 9 alarms. A System Error 9 alarm indicates a potential pressure loss in the pump cassette delivery chamber (chamber closest to the patient). This alarm is generated during the pumps initiation sequence and will not allow the set to be utilized. This requires a new set to be obtained, thus creating a potential for delay in therapy.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
FPA
Device Class
Class II
Regulation
21 CFR Part 880.5440
Advisory Committee
General Hospital
FDA Decision
SESE Substantially Equivalent

Other devices from Mcgaw, Inc.

See all devices from Mcgaw, Inc. →